Drexhage HA - Search Results

1

Thymostimulin enhancement of T-cell infiltration into head and neck squamous cell carcinoma.

Kerrebijn JD, Simons PJ, Balm AJ, Tas M, Knegt PP, de Vries N, Tan IB, Drexhage HA. Kerrebijn JD, et al. Among authors: drexhage ha. Head Neck. 1996 Jul-Aug;18(4):335-42. doi: 10.1002/(SICI)1097-0347(199607/08)18:4<335::AID-HED4>3.0.CO;2-Z. Head Neck. 1996. PMID: 8780944 Clinical Trial.

2

Macrophage and dendritic cell infiltration in head and neck squamous-cell carcinoma; an immunohistochemical study.

Kerrebijn JD, Balm AJ, Knegt PP, Meeuwis CA, Drexhage HA. Kerrebijn JD, et al. Among authors: drexhage ha. Cancer Immunol Immunother. 1994 Jan;38(1):31-7. doi: 10.1007/BF01517167. Cancer Immunol Immunother. 1994. PMID: 8299116 Free PMC article.

3

Depressed monocyte polarization and clustering of dendritic cells in patients with head and neck cancer: in vitro restoration of this immunosuppression by thymic hormones.

Tas MP, Simons PJ, Balm FJ, Drexhage HA. Tas MP, et al. Among authors: drexhage ha. Cancer Immunol Immunother. 1993;36(2):108-14. doi: 10.1007/BF01754410. Cancer Immunol Immunother. 1993. PMID: 8425208 Free PMC article.

4

In vivo effects of thymostimulin treatment on monocyte polarization, dendritic cell clustering and serum p15E-like trans-membrane factors in operable head and neck squamous cell carcinoma patients.

Kerrebijn JD, Simons PJ, Tas M, Balm AJ, Drexhage HA. Kerrebijn JD, et al. Among authors: drexhage ha. Eur Arch Otorhinolaryngol. 1995;252(7):409-16. doi: 10.1007/BF00167311. Eur Arch Otorhinolaryngol. 1995. PMID: 8562036 Clinical Trial.

5

Retroviral p15E-related serum factors and recurrence of head and neck cancer.

Tas MP, Laarman D, Haan-Meulman MD, Balm AJ, Snow GB, Drexhage HA. Tas MP, et al. Among authors: drexhage ha. Clin Otolaryngol Allied Sci. 1993 Aug;18(4):324-8. doi: 10.1111/j.1365-2273.1993.tb00857.x. Clin Otolaryngol Allied Sci. 1993. PMID: 8877195

6

The effects of thymostimulin on immunological function in patients with head and neck cancer.

Kerrebijn JD, Simons PJ, Tas M, Knegt PP, Van de Brekel MW, Delaere P, Tan IB, Drexhage HA, Balm AJ. Kerrebijn JD, et al. Among authors: drexhage ha. Clin Otolaryngol Allied Sci. 1996 Oct;21(5):455-62. doi: 10.1046/j.1365-2273.1996.00850.x. Clin Otolaryngol Allied Sci. 1996. PMID: 8932953 Clinical Trial.

7

Who is in control of the immune system in head and neck cancer?

Kerrebijn JD, Balm AJ, Freeman JL, Dosch HM, Drexhage HA. Kerrebijn JD, et al. Among authors: drexhage ha. Crit Rev Oncol Hematol. 1999 Jun;31(1):31-53. doi: 10.1016/s1040-8428(99)00011-6. Crit Rev Oncol Hematol. 1999. PMID: 10532189 Review. No abstract available.

8

Comparison of retroviral p15E-related factors and interferon alpha in head and neck cancer.

Simons PJ, Oostendorp RA, Tas MP, Drexhage HA. Simons PJ, et al. Among authors: drexhage ha. Cancer Immunol Immunother. 1994 Mar;38(3):178-84. doi: 10.1007/BF01525639. Cancer Immunol Immunother. 1994. PMID: 8124686 Free PMC article.

9

Immunosuppressive retroviral-related factors in sera of patients with head and neck cancer.

Tan IB, Balm AJ, Snow GB, Drexhage HA. Tan IB, et al. Among authors: drexhage ha. Eur Arch Otorhinolaryngol. 1990;247(6):387-90. doi: 10.1007/BF00179016. Eur Arch Otorhinolaryngol. 1990. PMID: 2278707

10

Immunoglobulin allotypes in head and neck cancer patients with multiple primary cancers.

de Vries N, de Lange G, Drexhage HA, Snow GB. de Vries N, et al. Among authors: drexhage ha. Acta Otolaryngol. 1987 Jul-Aug;104(1-2):187-91. doi: 10.3109/00016488709109066. Acta Otolaryngol. 1987. PMID: 3661161

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

313 results

Search Page

Filters